Derivative (1;7)(q10;p10) in a patient with de novo acute erythroblastic leukemia (AML-M6)

Cancer Genet Cytogenet. 1999 Nov;115(1):62-4. doi: 10.1016/s0165-4608(99)00076-x.

Abstract

A rare association of der(1;7)(q10;p10) with de novo acute erythroblastic leukemia (AML-M6) in a 63-year-old male is reported. While this unbalanced 1;7 translocation, der(1;7), has been reported often in therapy-related myelodysplastic syndrome (t-MDS) or therapy-related acute myeloid leukemia (t-AML), its associations with de novo AML-FAB-M6 have rarely been reported. Although der(1;7) has been reported as a cytogenetic factor for poor prognosis in t-MDS/AML, our patient showed a good response to chemotherapy and obtained complete remission, although longer observation is required to evaluate the prognosis.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Bone Marrow Cells / pathology
  • Chromosomes, Human, Pair 1*
  • Chromosomes, Human, Pair 7*
  • Humans
  • Karyotyping
  • Leukemia, Erythroblastic, Acute / genetics*
  • Leukemia, Erythroblastic, Acute / pathology
  • Lymphocyte Subsets
  • Male
  • Translocation, Genetic*